{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:06:24Z","timestamp":1784261184611,"version":"3.55.0"},"reference-count":40,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background: Antimicrobial resistance (AMR) threatens empirical therapy for invasive pediatric infections, but contemporary data from Serbia and the Western Balkans remain limited for blood and cerebrospinal fluid isolates. Methods: We performed a retrospective CAESAR-linked multicenter microbiological surveillance analysis of first eligible invasive bacterial isolates from hospitalized children in Serbia from 1 January 2020 to 31 December 2024. Organism distribution, ESBL production, carbapenemase marker results, and selected resistance outcomes were analyzed descriptively and with temporal trend and multivariable models. Results: Among 907 isolates, 879 (96.9%) were recovered from blood and 28 (3.1%) from cerebrospinal fluid; neonates and infants accounted for 57.9% of isolates. K. pneumoniae was the predominant organism (318\/907, 35.1%), followed by E. coli (172\/907, 19.0%), S. aureus (137\/907, 15.1%), and Acinetobacter spp. (96\/907, 10.6%). Among K. pneumoniae and E. coli isolates with available ESBL results, ESBL production was frequent, whereas carbapenemase testing was restricted to a selected subset and the carbapenemase type was not recorded in the national surveillance extract. In K. pneumoniae, meropenem resistance increased from 19.7% in 2020 to 48.6% in 2024, and later study years remained independently associated with meropenem resistance after adjustment. Conclusions: This microbiological surveillance study identifies K. pneumoniae predominance, neonatal concentration, frequent ESBL production, and a rising carbapenem-resistance signal as the principal findings among invasive pediatric isolates in Serbia. Resistance estimates, particularly carbapenemase production, should be interpreted as surveillance indicators rather than clinical prevalence estimates. These data support strengthened pediatric invasive-isolate surveillance, center- and age-specific antibiograms, molecular characterization, and coordinated antimicrobial stewardship and infection prevention and control efforts within the wider European AMR context.<\/jats:p>","DOI":"10.3390\/antibiotics15070694","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:12:38Z","timestamp":1784257958000},"page":"694","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic Resistance Profiles of Invasive Bacterial Isolates from Hospitalized Pediatric Patients in Serbia: A Multicenter Surveillance Study, 2020\u20132024"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5429-4639","authenticated-orcid":false,"given":"Deana","family":"Medic","sequence":"first","affiliation":[{"name":"Department of Microbiology with Parasitology and Immunology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia"},{"name":"Institute of Public Health of Vojvodina, Center for Microbiology and Virology, 21000 Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7855-5182","authenticated-orcid":false,"given":"Dusan Mihajlo","family":"Spasic","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Kukuric","sequence":"additional","affiliation":[{"name":"Department of Emergency Radiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Bajcetic","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global Burden of Bacterial Antimicrobial Resistance 1990\u20132021: A Systematic Analysis with Forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable Deaths and Disability-Adjusted Life-Years Caused by Infections with Antibiotic-Resistant Bacteria in the EU and the European Economic Area in 2015: A Population-Level Modelling Analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","article-title":"The Global Burden of Paediatric and Neonatal Sepsis: A Systematic Review","volume":"6","author":"Goldfarb","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(24)00430-4","article-title":"Global, Regional, and National Burden of Upper Respiratory Infections and Otitis Media, 1990\u20132021: A Systematic Analysis from the Global Burden of Disease Study 2021","volume":"25","author":"Sirota","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","article-title":"Global Antibiotic Consumption and Usage in Humans, 2000\u201318: A Spatial Modelling Study","volume":"5","author":"Browne","year":"2021","journal-title":"Lancet Planet. Health"},{"key":"ref_7","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2025). Antimicrobial Resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report for 2024, European Centre for Disease Prevention and Control (ECDC)."},{"key":"ref_8","unstructured":"WHO Regional Office for Europe and European Centre for Disease Prevention and Control (2026, June 01). Surveillance of Antimicrobial Resistance in Europe, 2024 Data: Executive Summary. Available online: https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289062619."},{"key":"ref_9","unstructured":"World Health Organization Regional Office for Europe (2019). Central Asian and European Surveillance of Antimicrobial Resistance: CAESAR Manual: Version 3.0, 2019, World Health Organization Regional Office for Europe. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/346572."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106441","DOI":"10.1016\/j.ijantimicag.2021.106441","article-title":"Antimicrobial Susceptibility among Gram-Negative Isolates in Pediatric Patients in Europe from 2013\u20132018 Compared to 2004\u20132012: Results from the ATLAS Surveillance Study","volume":"58","author":"Seifert","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhin.2023.05.021","article-title":"Antibiotic Resistance in Bloodstream Isolates from High-Complexity Paediatric Units in Madrid, Spain: 2013\u20132021","volume":"139","author":"Epalza","year":"2023","journal-title":"J. Hosp. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Medic, D., Bozic Cvijan, B., and Bajcetic, M. (2023). Impact of Antibiotic Consumption on Antimicrobial Resistance to Invasive Hospital Pathogens. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020259"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bajcetic, M., Spasic, D.M., Kukuric, M., Lukic, I., Milijic, A., and Rajkovic, D. (2026). Long-Term Public Antibiotic Awareness Campaign Significantly Reduced Inappropriate Antibiotic Use in Pediatric Primary Care Settings. Front. Public Health, 14.","DOI":"10.3389\/fpubh.2026.1730266"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Milic, M., Siljic, M., Cirkovic, V., Jovicevic, M., Perovic, V., Markovic, M., Martic, J., Stanojevic, M., and Mijac, V. (2021). Colonization with Multidrug-Resistant Bacteria in the First Week of Life among Hospitalized Preterm Neonates in Serbia: Risk Factors and Outcomes. Microorganisms, 9.","DOI":"10.3390\/microorganisms9122613"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mijac, V., Brkic, S., Milic, M., Siljic, M., Cirkovic, V., Perovic, V., Markovic, M., Cirkovic, I., and Stanojevic, M. (2023). Intestinal Colonization of Preterm Neonates with Carbapenem Resistant Enterobacteria at Hospital Discharge. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020284"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Brkic, S., and Cirkovic, I. (2024). Carbapenem-Resistant Enterobacterales in the Western Balkans: Addressing Gaps in European AMR Surveillance Map. Antibiotics, 13.","DOI":"10.3390\/antibiotics13090895"},{"key":"ref_17","unstructured":"World Health Organization (WHO) (2024). WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance, WHO."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41564-021-00870-7","article-title":"Characterization of Antimicrobial-Resistant Gram-Negative Bacteria That Cause Neonatal Sepsis in Seven Low- and Middle-Income Countries","volume":"6","author":"Sands","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mukherjee, S., Mitra, S., Dutta, S., and Basu, S. (2021). Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae. Front. Med., 8.","DOI":"10.3389\/fmed.2021.634349"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2327828","DOI":"10.1080\/14767058.2024.2327828","article-title":"Relevance and Antimicrobial Resistance Profile of Klebsiella pneumoniae in Neonatal Sepsis","volume":"37","author":"Ma","year":"2024","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mib.2018.04.004","article-title":"Klebsiella pneumoniae as a Key Trafficker of Drug Resistance Genes from Environmental to Clinically Important Bacteria","volume":"45","author":"Wyres","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14787210.2024.2305854","article-title":"Carbapenem-Resistant Klebsiella pneumoniae: The Role of Plasmids in Emergence, Dissemination, and Evolution of a Major Clinical Challenge","volume":"22","author":"Pollini","year":"2024","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Heil, E.L., Justo, J.A., Mathers, A.J., Satlin, M.J., and A Bonomo, R. (2024). Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin. Infect. Dis., ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Guidelines for the Treatment of Infections Caused by Multidrug-Resistant Gram-Negative Bacilli","volume":"28","author":"Paul","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_25","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2025). Carbapenem-Resistant Enterobacterales, Third Update\u20143 February 2025, ECDC."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jmii.2022.09.010","article-title":"Clinical Characteristics and Outcomes of Carbapenem-Resistant Enterobacterales Bacteremia in Pediatric Patients","volume":"56","author":"Liu","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ruvinsky, S., Voto, C., Roel, M., Portillo, V., Naranjo Zu\u00f1iga, G., Ulloa-Gutierrez, R., Comand\u00e9, D., Ciapponi, A., Aboud, G., and Brizuela, M. (2024). Carbapenem-Resistant Enterobacteriaceae Bacteremia in Pediatric Patients in Latin America and the Caribbean: A Systematic Review and Meta-Analysis. Antibiotics, 13.","DOI":"10.3390\/antibiotics13121117"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","article-title":"Uncovering the Mechanisms of Acinetobacter baumannii Virulence","volume":"16","author":"Harding","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Shi, J., Sun, T., Cui, Y., Wang, C., Wang, F., Zhou, Y., Miao, H., Shan, Y., and Zhang, Y. (2020). Multidrug Resistant and Extensively Drug Resistant Acinetobacter baumannii Hospital Infection Associated with High Mortality: A Retrospective Study in the Pediatric Intensive Care Unit. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05321-y"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Xu, G., Miao, F., Huang, W., Wang, H., and Wang, X. (2023). Insights into the Epidemiology, Risk Factors, and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Infections in Critically Ill Children. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1282413"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wu, X., Wang, C., He, L., Xu, H., Jing, C., Chen, Y., Lin, A., Deng, J., Cao, Q., and Deng, H. (2023). Antimicrobial Resistance Profile of Methicillin-Resistant Staphylococcus aureus Isolates in Children Reported from the ISPED Surveillance of Bacterial Resistance, 2016\u20132021. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1102779"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.2147\/IDR.S426000","article-title":"Bacterial Etiology and Antimicrobial Resistance Pattern of Pediatric Bloodstream Infections in Beijing, 2015\u20132019","volume":"16","author":"Lyu","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sajedi Moghaddam, S., Mamishi, S., Pourakbari, B., and Mahmoudi, S. (2024). Bacterial Etiology and Antimicrobial Resistance Pattern of Pediatric Bloodstream Infections: A 5-Year Experience in an Iranian Referral Hospital. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09260-w"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cid\/ciy834","article-title":"Emerging Resistance to Empiric Antimicrobial Regimens for Pediatric Bloodstream Infections in Malawi (1998\u20132017)","volume":"69","author":"Musicha","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1097\/INF.0b013e318286c612","article-title":"The Antibiotic Resistance and Prescribing in European Children Project","volume":"32","author":"Versporten","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/jac\/dkv418","article-title":"The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) Point Prevalence Survey: Developing Hospital-Quality Indicators of Antibiotic Prescribing for Children","volume":"71","author":"Versporten","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_37","unstructured":"World Health Organization Regional Office for Europe (2023). Roadmap on Antimicrobial Resistance for the WHO European Region 2023\u20132030 (RC73), WHO Regional Office for Europe."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., G\u00f8tzsche, P.C., Vandenbroucke, J.P. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040296"},{"key":"ref_39","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2024). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 14.0, 2024, EUCAST."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:52:45Z","timestamp":1784260365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["antibiotics15070694"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15070694","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}